Eli Lilly Expands Early Access Program for Experimental Weight Loss Drug Retatrutide
Product·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Eli Lilly is allowing more patients early access to its experimental weight loss drug retatrutide. Doctors are seeking ways to obtain the drug for their patients after one individual was granted early access.
Eli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Eli Lilly is allowing more patients early access to its experimental weight loss drug”
quartz — Eli Lilly is allowing more patients early access to its experimental weight loss drug“Doctors are asking how to get retatrutide for their patients, after Eli Lilly gave one man early access.”
stat news — STAT+: Eli Lilly to allow more patients to apply for special access to unapproved obesity drug